Use of palivizumab is underestimated in the Swedish Prescribed Drug Register – implications for register-based drug studies
Marie Linder,1 Camilla Byström,1 Helle Kieler,1 Gunnar Bergman,2 Ann Haerskjold3,4 1Centre for Pharmacoepidemiology, Department of Medicine, Karolinska Institutet, Solna, Stockholm, Sweden; 2Stockholm-Uppsala Department of Pediatric Cardiology, Astrid Lindgren Children's Hospital, K...
Main Authors: | Linder M, Byström C, Kieler H, Bergman G, Haerskjold A |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-12-01
|
Series: | Clinical Epidemiology |
Online Access: | http://www.dovepress.com/use-of-palivizumab-is-underestimated-in-the-swedish-prescribed-drug-re-peer-reviewed-article-CLEP |
Similar Items
-
Improved Survival in At-Risk Patients Undergoing Surveillance for Hepatocellular Carcinoma – A Nationwide Swedish Register-Based Study
by: Thörn R, et al.
Published: (2023-09-01) -
UPC barcode Apps for drug registered verification /
by: Fathin Noorshazlina Mohamad Roslan, 1992-, author, et al.
Published: (2015) -
UPC barcode apps for drug registered verification
by: Mohamad Roslan, F. N., et al.
Published: (2016) -
Using Registers to Study Effectiveness and Safety of Drugs
by: L. Yu. Drozdova, et al.
Published: (2014-07-01) -
Using Registers to Study Effectiveness and Safety of Drugs
by: L. Yu. Drozdova, et al.
Published: (2014-07-01)